Vertex Pharmaceuticals (VRTX) closed the latest trading day at $475.79, indicating a -1.19% change from the previous session's end. The stock fell short of the S&P 500, which registered a gain of 0.85% for the day. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq appreciated by 1.53%. Shares of the drugmaker have appreciated by 12.35% over the course of the past month, outperforming the Medical sector's gain of 2.46% and the S&P 500's gain of 3.11%. The investment community will be c ...